UNIVERSITY OF WISCONSIN–MADISON  |  UW HEALTH

TEAM

CONTACT

CAREERS

SUBSCRIBE

Multi-color pills

08 Jul Could a Cancer Drug Curb the Organ Damage of Severe COVID?

Posted at 13:26h in Clinical Trials, Clinical Research by

By Dennis Thompson, HealthDay

MONDAY, July 8, 2024 (HealthDay News) — An experimental cancer drug might be able to help prevent the organ damage caused by severe COVID infections, a new study finds.

The drug, called eganelisib, inhibits an immune system enzyme called PI3K gamma that boosts damaging inflammation in cancerous tumors.

But lab studies in mice and human tissue showed that eganelisib could also be effective in suppressing organ-damaging inflammation caused by COVID, according to findings published July 3 in the journal Science Translational Medicine. Read more…